11 research outputs found

    Editorial comment

    No full text

    Anticoagulation in pregnancy and the puerperium

    No full text
    For the management of acute thrombotic events in pregnancy therapeutic doses of low molecular weight heparins (LMWH) may be used, unless the shorter half-life of intravenous unfractionated heparin (UH) and predictable reversibility by protamine are important. Treatment should be continued up until delivery and into the puerperium
    corecore